Shifting Tides: A Wall Street Perspective on Biotech Deal-making in the Current Global Climate

4:30 PM - 5:45 PM (EST), Monday, February 10, 2020 ・ Lyceum Complex
Despite a record number of large deals across the pharmaceutical and biotechnology landscape, market indicators are pointing toward a noticeable shift in the appetite for global deal-making across the industry. As the pool of high-valued assets becomes smaller, will signs point to a drastic increase in smaller deals for larger pharma companies looking to solidify their balance sheets across core therapeutic areas? How does a strong public market with a well-capitalized pool of young biotech targets that don’t need to be forced into an early buyout impact this hypothetical M&A shift? This session will feature experienced voices explaining the public perspective for a potentially active year within pharma and biotech deal-making.
Moderator
photo
Partner
Morrison & Foerster LLP
Speakers
photo
Managing Director and Co-Head of Healthcare Investment Banking
Raymond James
photo
CEO and Co-Founder
Locust Walk
photo
Venture Partner
BVCF Management, Ltd.
photo
Vice Chairman
J.P. Morgan
photo
Partner
Centerview Partners LLC